Advertisement

AIDS and Behavior

, Volume 18, Issue 4, pp 646–660 | Cite as

Identification of Evidence-Based Interventions for Promoting HIV Medication Adherence: Findings from a Systematic Review of U.S.-Based Studies, 1996–2011

  • Mahnaz R. Charania
  • Khiya J. Marshall
  • Cynthia M. Lyles
  • Nicole Crepaz
  • Linda S. Kay
  • Linda J. Koenig
  • Paul J. Weidle
  • David W. Purcell
  • HIV/AIDS Prevention Research Synthesis (PRS) Team
Substantive Review

Abstract

A systematic review was conducted to identify evidence-based interventions (EBIs) for increasing HIV medication adherence behavior or decreasing HIV viral load among persons living with HIV (PLWH). We conducted automated searches of electronic databases (i.e., MEDLINE, EMBASE, PsycINFO, CINAHL) and manual searches of journals, reference lists, and listservs. Interventions were eligible for the review if they were U.S.-based, published between 1996 and 2011, intended to improve HIV medication adherence behaviors of PLWH, evaluated the intervention using a comparison group, and reported outcome data on adherence behaviors or HIV viral load. Each intervention was evaluated on the quality of study design, implementation, analysis, and strength of findings. Of the 65 eligible interventions, 10 are EBIs. The remaining 55 interventions failed to meet the efficacy criteria primarily due to null findings, small sample sizes, or low retention rates. Research gaps and future directions for development of adherence EBIs are discussed.

Keywords

HIV/AIDS Intervention Medication adherence Evidence-based Antiretroviral therapy 

Resumen

Se realizó una revisión sistemática para identificar intervenciones eficaces en aumentando comportamientos para tomar medicinas para VIH en manera prescrita (adherencia a medicamentos) o disminuyendo la carga viral de VIH detectada en la sangre (carga viral) entre personas viviendo con VIH. Realizamos búsquedas automatizadas de bases de datos electrónicas (es decir MEDLINE, EMBASE, PsycINFO, CINAHL) y búsquedas manuales de revistas, listas de referencia, y listservs. Las intervenciones fueron elegibles para la revisión, si fueron basadas en los EEUU, publicadas entre 1996 y 2011, intentaron mejorar los comportamientos de personas viviendo con VIH en tomar sus medicinas en manera prescrita, evaluaron la intervención usando un grupo de comparación, y reportaron los datos de resultados de los comportamientos de adherencia a medicamentos o carga viral del VIH. Se evaluó cada intervención sobre la calidad del diseño del estudio, implementación, análisis y validez de los resultados. De las 65 intervenciones elegibles, 10 fueron intervenciones identificadas como eficaz. Las 55 intervenciones que sobraron no cumplieron con los criterios de eficacia, principalmente debido a retención baja, tamaños de muestra pequeños o nulos resultados. Hoyos en los estudios y direcciones futuras para el desarrollo de intervenciones eficaces en aumentando adherencia a medicamentos se discuten.

Palabras Claves

VIH/SIDA Intervención Adherencia a medicamentos Intervenciones eficaces Terapia antiviral 

Notes

Acknowledgments

The authors would like to thank the following external consultants for providing invaluable insight and feedback on the medication adherence criteria development process: Rivet Amico, Deborah L. Jones, Robert H. Remien, Steven Safren, Jane Simoni, Ann Williams, and Ira Wilson. The authors would also like to thank all principal investigators of the original research who facilitated our review process by providing the necessary additional information or analyses as requested by PRS. Other members of the HIV/AIDS Prevention Research Synthesis Team who contributed to this review (listed alphabetically): Adebukola Adegbite (ICF International), Brittney Baack (CDC), Terrika Barham (ICF International), Mary M. Mullins (CDC), and Maria Luisa Tungol (CDC). This work was supported by the Prevention Research Branch, Division of HIV/AIDS Prevention, U.S. Centers for Disease Control and Prevention and was not funded by any other organization.

Disclaimer

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.

Supplementary material

10461_2013_594_MOESM1_ESM.docx (26 kb)
Supplementary material 1 (DOCX 26 kb)

References

  1. 1.
    Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Washington, DC:Office of National AIDS Policy. http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf. Accessed 10 June 2013.
  2. 2.
    Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007;146(2):87–95.PubMedGoogle Scholar
  3. 3.
    Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2011;26(3):335–43.Google Scholar
  4. 4.
    van Sighem AI, Gras LA, Reiss P, Brinkman K, De Wolf F, Athena National Observational Cohort Study. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS. 2010;24(10):1527–35.PubMedGoogle Scholar
  5. 5.
    CDC. High-Impact HIV Prevention: CDC’s approach to reducing HIV infections in the United States. Atlanta, GA. Centers for Disease Control and Prevention. http://www.cdc.gov/hiv/strategy/hihp/report/index.htm. Accessed 10 June 2013.
  6. 6.
    Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care Panel. Ann Intern Med. 2012;156(11):817–33.PubMedGoogle Scholar
  7. 7.
    Bartlett JA. Addressing the challenges of adherence. J Acquir Immune Defic Syndr. 2002;29(Suppl 1):S2–10.PubMedGoogle Scholar
  8. 8.
    Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Infect Dis. 2000;30(Suppl 2):S171–6.PubMedGoogle Scholar
  9. 9.
    Gardner EM, Maravi ME, Rietmeijer C, Davidson AJ, Burman WJ. The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care. Appl Health Econ Health Policy. 2008;6(2–3):145–55.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedGoogle Scholar
  11. 11.
    Atkinson MJ, Petrozzino JJ. An evidence-based review of treatment-related determinants of patients’ nonadherence to HIV medications. AIDS Patient Care STDS. 2009;23(11):903–14.PubMedGoogle Scholar
  12. 12.
    Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedGoogle Scholar
  13. 13.
    Bangsberg DR. Less than 95 % adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939–41.PubMedGoogle Scholar
  14. 14.
    Howard AA, Arnsten JH, Lo Y, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002;16(16):2175–82.PubMedGoogle Scholar
  15. 15.
    Lima VD, Geller J, Bangsberg DR, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS. 2007;21(9):1175–83.PubMedGoogle Scholar
  16. 16.
    Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115–21.PubMedGoogle Scholar
  17. 17.
    Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146(8):564–73.PubMedGoogle Scholar
  18. 18.
    Sullivan PS, Campsmith ML, Nakamura GV, Begley EB, Schulden J, Nakashima AK. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE. 2007;2(6):e552.PubMedCentralPubMedGoogle Scholar
  19. 19.
    Zaragoza-Macias E, Cosco D, Nguyen ML, Del Rio C, Lennox J. Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Res Hum Retrovir. 2010;26(2):133–8.PubMedCentralPubMedGoogle Scholar
  20. 20.
    Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCentralPubMedGoogle Scholar
  21. 21.
    Hall HI, Frazier EL, Rhodes P, et al. Continuum of care: differences in care and treatment by sex and race/ethnicity in the United States. In: Proceedings of the XIX International AIDS Conference; 2012 July 22–27; Washington, DC; [Abstract FRLBX05].Google Scholar
  22. 22.
    Ortego C, Huedo-Medina TB, Llorca J, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381–96.PubMedGoogle Scholar
  23. 23.
    Ammassari A, Trotta MP, Murri R, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S123–7.PubMedGoogle Scholar
  24. 24.
    Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCentralPubMedGoogle Scholar
  25. 25.
    Reisner SL, Mimiaga MJ, Skeer M, Perkovich B, Johnson CV, Safren SA. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17(1):14–25.PubMedCentralPubMedGoogle Scholar
  26. 26.
    Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119(6):e1371–83.PubMedGoogle Scholar
  27. 27.
    Fogarty L, Roter D, Larson S, Burke J, Gillespie J, Levy R. Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Educ Couns. 2002;46(2):93–108.PubMedGoogle Scholar
  28. 28.
    Sandelowski M, Voils CI, Chang Y, Lee EJ. A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care. 2009;21(8):953–66.PubMedCentralPubMedGoogle Scholar
  29. 29.
    Bae JW, Guyer W, Grimm K, Altice FL. Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research. AIDS. 2011;25(3):279–90.PubMedGoogle Scholar
  30. 30.
    Gonzalez JS, Batchelder AW, Psaros C, Safren SA. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.PubMedGoogle Scholar
  31. 31.
    Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14(4):731–47.PubMedGoogle Scholar
  32. 32.
    Wutoh AK, Elekwachi O, Clarke-Tasker V, Daftary M, Powell NJ, Campusano G. Assessment and predictors of antiretroviral adherence in older HIV-infected patients. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S106–14.PubMedGoogle Scholar
  33. 33.
    Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedGoogle Scholar
  34. 34.
    Heyer A, Ogunbanjo GA. Adherence to HIV antiretroviral therapy. Part I: a review of factors that influence adherence. S Afr Fam Pract. 2006;48(8):5–9.Google Scholar
  35. 35.
    Leeman J, Chang YK, Lee EJ, Voils CI, Crandell J, Sandelowski M. Implementation of antiretroviral therapy adherence interventions: a realist synthesis of evidence. J Adv Nurs. 2010;66(9):1915–30.PubMedCentralPubMedGoogle Scholar
  36. 36.
    Malta M, Petersen ML, Clair S, Freitas F, Bastos FI. Adherence to antiretroviral therapy: a qualitative study with physicians from Rio de Janeiro, Brazil. Cad Saude Publica. 2005;21(5):1424–32.PubMedGoogle Scholar
  37. 37.
    Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedGoogle Scholar
  38. 38.
    Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7(1):44–51.PubMedCentralPubMedGoogle Scholar
  39. 39.
    Lyles CM, Crepaz N, Herbst JH, Kay LS. Evidence-based HIV behavioral prevention from the perspective of the CDC’s HIV/AIDS Prevention Research Synthesis Team. AIDS Educ Prev. 2006;18(4 Suppl A):21–31.PubMedGoogle Scholar
  40. 40.
    Altice FL, Maru DS, Bruce RD, Springer SA, Friedland GH. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis. 2007;45(6):770–8.PubMedCentralPubMedGoogle Scholar
  41. 41.
    Johnson MO, Charlebois E, Morin SF, Remien RH, Chesney MA. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr. 2007;46(5):574–80.PubMedCentralPubMedGoogle Scholar
  42. 42.
    Kalichman SC, Cherry C, Kalichman MO, et al. Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission. Am J Public Health. 2011;101(3):531–8.PubMedCentralPubMedGoogle Scholar
  43. 43.
    Koenig LJ, Pals SL, Bush T, Pratt PM, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159–69.PubMedGoogle Scholar
  44. 44.
    Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clin Infect Dis. 2006;42(11):1628–35.PubMedGoogle Scholar
  45. 45.
    Milam J, Richardson JL, McCutchan A, et al. Effect of a brief antiretroviral adherence intervention delivered by HIV care providers. J Acquir Immune Defic Syndr. 2005;40(3):356–63.PubMedGoogle Scholar
  46. 46.
    Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19(8):807–14.PubMedGoogle Scholar
  47. 47.
    Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr. 2009;52(4):465–73.PubMedCentralPubMedGoogle Scholar
  48. 48.
    Williams AB, Fennie KP, Bova CA, Burgess JD, Danvers KA, Dieckhaus KD. Home visits to improve adherence to highly active antiretroviral therapy: a randomized controlled trial. J Acquir Immune Defic Syndr. 2006;42(3):314–21.PubMedGoogle Scholar
  49. 49.
    Bandura A. Social cognitive theory and excercise of control over HIV infection. In: DiClemente RJ, Peterson JL, editors. Preventing AIDS: theories and methods of behavioral preventions. New York: Plenum Press; 1994. p. 25–59.Google Scholar
  50. 50.
    Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74–81.PubMedGoogle Scholar
  51. 51.
    Deci E. Intrinsic motivation and self-determination in human behavior. New York: Plenum Press; 1985.Google Scholar
  52. 52.
    D’Zurilla TJ, Nezu A. Social problem solving in adults. In: Kendall P, editor. Advances in cognitive-behavioral research and therapy, vol. 1. New York: Academic Press; 1982. p. 202–74.Google Scholar
  53. 53.
    Freire P. Pedagogy of the oppressed. New York: Continuum Press; 1986.Google Scholar
  54. 54.
    Ewart CK. Social action theory for a public health psychology. Am Psychol. 1991;46(9):931–46.PubMedGoogle Scholar
  55. 55.
    Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22(2):223–8.PubMedGoogle Scholar
  56. 56.
    Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39(10):1151–62.PubMedGoogle Scholar
  57. 57.
    Smith SR, Rublein JC, Marcus C, Brock TP, Chesney MA. A medication self-management program to improve adherence to HIV therapy regimens. Patient Educ Couns. 2003;50(2):187–99.PubMedGoogle Scholar
  58. 58.
    McPherson-Baker S, Malow RM, Penedo F, Jones DL, Schneiderman N, Klimas NG. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care. 2000;12(4):399–404.PubMedGoogle Scholar
  59. 59.
    Jones DL, Ishii M, LaPerriere A, et al. Influencing medication adherence among women with AIDS. AIDS Care. 2003;15(4):463–74.PubMedGoogle Scholar
  60. 60.
    Rawlings MK, Thompson MA, Farthing CF, et al. Impact of an educational program on efficacy and adherence with a twice-daily Lamivudine/Zidovudine/Abacavir regimen in underrepresented HIV-infected patients. J Acquir Immune Defic Syndr. 2003;34(2):174–83.PubMedGoogle Scholar
  61. 61.
    Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care. 2003;15(6):787–93.PubMedGoogle Scholar
  62. 62.
    Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med. 2000;15(12):841–7.PubMedCentralPubMedGoogle Scholar
  63. 63.
    Rotheram-Borus MJ, Swendeman D, Comulada WS, Weiss RE, Lee M, Lightfoot M. Prevention for substance-using HIV-positive young people: telephone and in-person delivery. J Acquir Immune Defic Syndr. 2004;37(Suppl. 2):S68–77.PubMedCentralPubMedGoogle Scholar
  64. 64.
    Wyatt GE, Longshore D, Chin D, et al. The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories. AIDS Behav. 2004;8(4):453–62.PubMedGoogle Scholar
  65. 65.
    Berrien VM, Salazar JC, Reynolds E, McKay K, HIV Medication Adherence Intervention Group. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care STDS. 2004;18(6):355–63.PubMedGoogle Scholar
  66. 66.
    Murphy DA, Lu MC, Martin D, Hoffman D, Marelich WD. Results of a pilot intervention trial to improve antiretroviral adherence among HIV-positive patients. J Assoc Nurses AIDS Care. 2002;13(6):57–69.PubMedGoogle Scholar
  67. 67.
    Rathbun RC, Farmer KC, Stephens JR, Lockhart SM. Impact of an adherence clinic on behavioral outcomes and virologic response in treatment of HIV infection: a prospective, randomized, controlled pilot study. Clin Ther. 2005;7(2):199–209.Google Scholar
  68. 68.
    DiIorio C, Resnicow K, McDonnell M, Soet J, McCarty F, Yeager K. Using motivational interviewing to promote adherence to antiretroviral medications: a pilot study. J Assoc Nurses AIDS Care. 2003;14(2):52–62.PubMedGoogle Scholar
  69. 69.
    Samet JH, Horton NJ, Meli S, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005;10(1):83–93.PubMedGoogle Scholar
  70. 70.
    Antoni MH, Carrico AW, Duran RE, et al. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosom Med. 2006;68(1):143–51.PubMedGoogle Scholar
  71. 71.
    Golin CE, Earp J, Tien HC, Stewart P, Porter C, Howie L. A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. J Acquir Immune Defic Syndr. 2006;42(1):42–51.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Wagner GJ, Kanouse DE, Golinelli D, et al. Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578). AIDS. 2006;20(9):1295–302.PubMedGoogle Scholar
  73. 73.
    Javanbakht M, Prosser P, Grimes T, Weinstein M, Farthing C. Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial. J Int Assoc Physicians AIDS Care. 2006;5(4):143–50.Google Scholar
  74. 74.
    Rosen MI, Dieckhaus K, McMahon TJ, et al. Improved adherence with contingency management. AIDS Patient Care STDS. 2007;21(1):30–40.PubMedGoogle Scholar
  75. 75.
    Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26(4):488–95.PubMedGoogle Scholar
  76. 76.
    Jones DL, McPherson-Baker S, Lydston D, et al. Efficacy of a group medication adherence intervention among HIV positive women: the SMART/EST Women’s Project. AIDS Behav. 2007;11(1):79–86.PubMedCentralPubMedGoogle Scholar
  77. 77.
    Purcell DW, Latka MH, Metsch LR, et al. Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007;46(Suppl. 2):S35–47.PubMedGoogle Scholar
  78. 78.
    Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46(4):443–50.PubMedCentralPubMedGoogle Scholar
  79. 79.
    Naar-King S, Lam P, Wang B, Wright K, Parsons JT, Frey MA. Brief report: maintenance of effects of motivational enhancement therapy to improve risk behaviors and HIV-related health in a randomized controlled trial of youth living with HIV. J Pediatr Psychol. 2008;33(4):441–5.PubMedGoogle Scholar
  80. 80.
    Wohl AR, Garland WH, Valencia R, et al. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis. 2006;42(11):1619–27.PubMedGoogle Scholar
  81. 81.
    Andrade AS, McGruder HF, Wu AW, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis. 2005;41(6):875–82.PubMedGoogle Scholar
  82. 82.
    DiIorio C, McCarty F, Resnicow K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.PubMedCentralPubMedGoogle Scholar
  83. 83.
    Westling E, Garcia K, Mann T. Discovery of meaning and adherence to medications in HIV-infected women. J Health Psychol. 2007;12(4):627–35.PubMedGoogle Scholar
  84. 84.
    Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–7.PubMedGoogle Scholar
  85. 85.
    Van Servellen G, Nyamathi A, Carpio F, et al. Effects of a treatment adherence enhancement program on health literacy, patient-provider relationships, and adherence to HAART among low-income HIV-positive Spanish-speaking Latinos. AIDS Patient Care STDS. 2005;19(11):745–59.PubMedGoogle Scholar
  86. 86.
    Reynolds NR, Testa MA, Su M, et al. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr. 2008;47(1):62–8.PubMedGoogle Scholar
  87. 87.
    Safren SA, O’Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT–AD) in HIV-infected individuals. Health Psychol. 2009;28(1):1–10.PubMedCentralPubMedGoogle Scholar
  88. 88.
    Enriquez M, Cheng AL, McKinsey DS, Stanford J. Development and efficacy of an intervention to enhance readiness for adherence among adults who had previously failed HIV treatment. AIDS Patient Care STDS. 2009;23(3):177–84.PubMedGoogle Scholar
  89. 89.
    Visnegarwala F, Rodriguez-Barradass MC, Graviss EA, Caprio M, Nykyforchyn M, Laufman L. Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART. AIDS Care. 2006;18(4):332–8.PubMedGoogle Scholar
  90. 90.
    Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S41–7.PubMedGoogle Scholar
  91. 91.
    Levin TR, Klibanov OM, Axelrod P, et al. A randomized trial of educational materials, pillboxes, and mailings to improve adherence with antiretroviral therapy in an Inner City HIV clinic. J Clin Outcomes Manag. 2006;13(4):217–21.Google Scholar
  92. 92.
    Sorensen JL, Haug NA, Delucchi KL, et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007;88(1):54–63.PubMedCentralPubMedGoogle Scholar
  93. 93.
    Murphy DA, Marelich WD, Rappaport NB, Hoffman D, Farthing C. Results of an antiretroviral adherence intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly). J Int Assoc Provid AIDS Care. 2007;6(2):113–24.Google Scholar
  94. 94.
    Webel AR. Testing a peer-based symptom management intervention for women living with HIV/AIDS. AIDS Care. 2010;22(9):1029–40.PubMedCentralPubMedGoogle Scholar
  95. 95.
    Berg KM, Litwin A, Li X, Heo M, Arnsten JH. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial. Drug Alcohol Depend. 2011;113(2–3):192–9.PubMedCentralPubMedGoogle Scholar
  96. 96.
    Johnson MO, Dilworth SE, Taylor JM, Neilands TB. Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV. Ann Behav Med. 2011;41(1):83–91.PubMedCentralPubMedGoogle Scholar
  97. 97.
    Fisher JD, Amico KR, Fisher WA, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav. 2011;15(8):1635–46.PubMedGoogle Scholar
  98. 98.
    Ingersoll KS, Farrell-Carnahan L, Cohen-Filipic J, et al. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Drug Alcohol Depend. 2011;116(1–3):177–87.PubMedCentralPubMedGoogle Scholar
  99. 99.
    Hardy H, Kumar V, Doros G, et al. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS. 2011;25(3):153–61.PubMedCentralPubMedGoogle Scholar
  100. 100.
    Kalichman SC, Kalichman MO, Cherry C, et al. Brief behavioral self-regulation counseling for HIV treatment adherence delivered by cell phone: an initial test of concept trial. AIDS Patient Care STDS. 2011;25(5):303–10.PubMedCentralPubMedGoogle Scholar
  101. 101.
    Holstad MM, DiIorio C, Kelley ME, Resnicow K, Sharma S. Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women. AIDS Behav. 2011;15(5):885–96.PubMedCentralPubMedGoogle Scholar
  102. 102.
    Duncan LG, Moskowitz JT, Neilands TB, Dilworth SE, Hecht FM, Johnson MO. Mindfulness-based stress reduction for HIV treatment side effects: a randomized, wait-list controlled trial. J Pain Symptom Manage. 2012;43(2):161–71.PubMedCentralPubMedGoogle Scholar
  103. 103.
    Lyles CM, Kay LS, Crepaz N, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000–2004. Am J Public Health. 2007;97(1):133–43.PubMedCentralPubMedGoogle Scholar
  104. 104.
    Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication adherence in research. AIDS Behav. 2012;17(1):284–97.Google Scholar
  105. 105.
    Committee on HIV Prevention in the United States, Division of Health Promotion and Disease Prevention. No time to lose: getting more from HIV prevention. Washington, DC: National Academies Press; 2001.Google Scholar
  106. 106.
    Committee on Assuring the Health of the Public in the 21st Century. The future of the public’s health in the 21st century. Washington, DC: National Academies Press; 2002.Google Scholar
  107. 107.
    Collins C, Harshbarger C, Sawyer R, Hamdallah M. The diffusion of effective behavioral interventions project: development, implementation, and lessons learned. AIDS Educ Prev. 2006;18(4 Suppl A):5–20.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York (outside the USA) 2013

Authors and Affiliations

  • Mahnaz R. Charania
    • 1
  • Khiya J. Marshall
    • 1
  • Cynthia M. Lyles
    • 1
  • Nicole Crepaz
    • 1
  • Linda S. Kay
    • 1
  • Linda J. Koenig
    • 1
  • Paul J. Weidle
    • 1
  • David W. Purcell
    • 1
  • HIV/AIDS Prevention Research Synthesis (PRS) Team
    • 1
  1. 1.Division of HIV/AIDS Prevention, National Center for HIV, STD and TB PreventionCenters for Disease Control and PreventionAtlantaUSA

Personalised recommendations